1. Home
  2. Live Updates
  3. Onclive tv

Live Breaking News & Updates on Onclive tv

Stay informed with the latest breaking news from Onclive tv on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Onclive tv and stay connected to the pulse of your community

Dr Olivares on Focal Therapy in the Management of Prostate Cancer

Ruben Olivares, MD, discusses focal therapy in the management of prostate cancer.

Ruben-olivares , Glickman-urological-institute , Cleveland-clinic , Leveland-clinic , Onclive-tv , Prostate-cancer ,

Dr Kopetz on the Background of the KRYSTAL-1 Trial in KRAS G12C+ mCRC

Scott Kopetz, MD, PhD, FACP, discusses using adagrasib plus cetuximab in patients with metastatic colorectal cancer harboring KRAS G12C mutations.

Texas , United-states , Scott-kopetz , University-of-texas-md-anderson-cancer-center , Translational-integration , Cancer-center , He-university-of-texas-md-anderson-cancer-center , Onclive-tv , Colorectal-cancer ,

Dr Nanda on the Evolution of CDK4/6 Inhibitor Treatment in HR+/HER2– Breast Cancer

Rita Nanda, MD, discusses the evolution of treatment with CDK4/6 inhibitors in patients with hormone receptor-positive/HER2-negative breast cancer.

Rita-nanda , Breast-oncology-program , University-of-chicago , Science-summit , Niversity-of-chicago-medicine-comprehensive-cancer-center , Onclive-tv , Breast-cancer ,

Dr Jain on Unmet Needs in the Treatment of Low- and High-Risk MDS

Akriti Jain, MD, discusses unmet needs in patients with low- and high-risk myelodysplastic syndromes.

Akriti-jain , Department-of-hematology , Medical-oncology , Cleveland-clinic , Myeloproliferative-neoplasms , Onclive-tv ,

Dr Singh on Unmet Medical Needs in Lung Cancer Treatment

Raj Singh, MD, discusses unmet medical needs in the treatment of patients with lung cancer.

Raj-singh , Ohio-state-university-comprehensive-cancer-center , He-ohio-state-university-comprehensive-cancer-center-james , Onclive-tv , Lung-cancer ,

Dr Eroglu on the Safety Profile of Ceritinib Plus Trametinib in Advanced Melanoma

Zeynep Eroglu, MD, discusses the safety profile of ceritinib plus trametinib in pretreated metastatic melanoma.

Zeynep-eroglu , University-of-south-florida , Moffitt-cancer-center , Department-of-oncologic-sciences , Department-of-cutaneous-oncology , Morsani-college-of-medicine , Cutaneous-oncology , Oncologic-sciences , South-florida , Morsani-college , Melanoma , Skin-cancer

Dr Konecny on PROs With Mirvetuximab Soravtansine in Advanced Ovarian Cancer

Gottfried Konecny, MD, discusses patient-reported outcomes from the phase 3 MIRASOL trial in platinum-resistant ovarian cancer.

Los-angeles , California , United-states , Gottfried-konecny , Department-of-medicine , Los-angeles-health , University-of-california , Cla-health-jonsson-comprehensive-cancer-center , Ovarian-cancer , Onclive-tv ,

Dr Srour on the Ongoing Investigation of CAR T-Cell Therapy in Advanced RCC

Samer A. Srour, MB ChB, MS, discusses the investigation of the allogeneic CAR T-cell therapy CTX131 in advanced clear cell renal cell carcinoma.

Texas , United-states , Samera-srour , Division-of-cancer-medicine , Department-of-stem-cell-transplantation , University-of-texas-md-anderson-cancer-center , Stem-cell-transplantation , Cellular-therapy , Cancer-medicine , Cancer-center , He-university-of-texas-md-anderson-cancer-center

Dr Usmani on the Design of the CARTITUDE-4 Trial in Multiple Myeloma

Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the design of the phase 3 CARTITUDE-4 trial in multiple myeloma.

Saadz-usmani , Memorial-sloan-kettering-cancer-center , Myeloma-service , Emorial-sloan-kettering-cancer-center , Onclive-tv , Multiple-myeloma ,

Dr Kristeleit on the Implications of Long-Term Data With Rucaparib in Advanced Ovarian Cancer

Rebecca Kristeleit, BSc, MBChB, MRCP, PhD, discusses the ATHENA-MONO trial in newly diagnosed patients with advanced ovarian cancer.

United-states , Rebecca-kristeleit , London-cancer-institute , European-medicines-agency , University-college , Department-of-oncology , University-college-london-cancer-institute , Onclive-tv , Varian-cancer , Gynecologic-oncology ,